title: [Treatment of intracranial hemorrhage in chronic idiopathic thrombocytopenic purpura].
abstract: Conventional treatment of two patients with chronic idiopathic thrombocytopenic purpura (CITP) and petechial intracranial hemorrhage was ineffectual. However, after a treatment with vincristine, the neurological manifestations disappeared and platelet counts improved; clinical recovery was complete. This success contrast with results informed in similar patients treated with corticosteroids or splenectomy, among whom the mortality is as high as 100%. The favorable reaction may be related to the various mechanisms of the action of vincristine, which usually lead to control of CITP. The use of this drug is proposed in association of conventional therapy of this severe complication, especially in patients in whom splenectomy is contraindicated.
authors.forename: M R
authors.initials: MR
authors.lastname: Morales-Polanco
authors.forename: E
authors.initials: E
authors.lastname: Sánchez-Valle
authors.forename: L A
authors.initials: LA
authors.lastname: Meillón-García
authors.forename: B
authors.initials: B
authors.lastname: Batista-Guizar
mesh_terms: D000368:Aged; D002543:Cerebral Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D002908:Chronic Disease; D005260:Female; D006801:Humans; D008875:Middle Aged; D010976:Platelet Count; D011696:Purpura, Thrombocytopenic / Q000150:complications*; D014750:Vincristine / Q000627:therapeutic use*
chemical_list: D014750:Vincristine
vernacular_title: Tratamiento de la hemorragia intracraneana en la púrpura trombocitopénica idiopática crónica.